Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma
Boehringer Ingelheim
Boehringer Ingelheim
Boehringer Ingelheim
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Pfizer
Epkin
Eli Lilly and Company
Shanghai Pharma Biotherapeutics USA Inc.
Lamassu Bio Inc
Ascentage Pharma Group Inc.
Rain Oncology Inc
Pfizer
Sumitomo Pharma America, Inc.
Pfizer
OncoResponse, Inc.
Karyopharm Therapeutics Inc
Novartis
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Xian-Janssen Pharmaceutical Ltd.
Novartis
Valerio Therapeutics
Valerio Therapeutics
Infinity Pharmaceuticals, Inc.
Merck Sharp & Dohme LLC
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Daiichi Sankyo